David Ivancic
Overview
Explore the profile of David Ivancic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarami I, Hekman K, Gupta A, Snider J, Ivancic D, Zec M, et al.
bioRxiv
. 2025 Mar;
PMID: 40060393
Metabolic pathways play a critical role in driving differentiation but remain poorly understood in the development of kidney organoids. In this study, parallel metabolite and transcriptome profiling of differentiating human...
2.
Ferrer J, Sinegra A, Ivancic D, Yeap X, Qiu L, Wang J, et al.
ACS Nano
. 2020 Jan;
14(2):1682-1693.
PMID: 31951368
Spherical nucleic acids (SNAs) are a class of nanomaterials with a structure defined by a radial distribution of densely packed, short DNA or RNA sequences around a nanoparticle core. This...
3.
Lee O, Heinz R, Ivancic D, Muzzio M, Chatterton R, Zalles C, et al.
Cancer Prev Res (Phila)
. 2018 Jun;
11(9):557-568.
PMID: 29954758
Sex steroid hormones contribute to breast cancer development, but data on concentrations of these within breast tissue are limited. We performed simultaneous multiparameter measurement of breast sex steroids, breast epithelial...
4.
Brown J, Das P, DiVito M, Ivancic D, Tan L, Wertheim J
Acta Biomater
. 2018 Feb;
73:217-227.
PMID: 29454157
Statement Of Significance: Culturing primary hepatocytes within a three-dimensional (3D) structure that mimics the natural liver environment is a promising strategy for extending the function and viability of hepatocytes in...
5.
Wang J, Shidfar A, Ivancic D, Ranjan M, Liu L, Choi M, et al.
Int J Cancer
. 2017 Mar;
140(11):2484-2497.
PMID: 28263391
Risk biomarkers for estrogen receptor (ER)-negative breast cancer have clear value for breast cancer prevention. We previously reported a set of lipid metabolism (LiMe) genes with high expression in the...
6.
Stearns V, Fackler M, Hafeez S, Bujanda Z, Chatterton R, Jacobs L, et al.
Cancer Prev Res (Phila)
. 2016 Jun;
9(8):673-682.
PMID: 27261491
Methods to determine individualized breast cancer risk lack sufficient sensitivity to select women most likely to benefit from preventive strategies. Alterations in DNA methylation occur early in breast cancer. We...
7.
Shidfar A, Fatokun T, Ivancic D, Chatterton R, Khan S, Wang J
Horm Cancer
. 2016 Apr;
7(4):252-9.
PMID: 27094399
The local endocrine environment of the breast may have stronger relations to breast cancer risk than systemic hormones. Nipple aspiration fluid (NAF) provides a window into this milieu. We hypothesized...
8.
Lee O, Choi M, Christov K, Ivancic D, Khan S
Cancer Lett
. 2016 Apr;
376(2):310-7.
PMID: 27080304
Purpose: Blockade of the progestogen-progesterone receptor (PR) axis is a novel but untested strategy for breast cancer prevention. We report preclinical data evaluating telapristone acetate (TPA), ulipristal acetate (UPA), and...
9.
Chatterton R, Heinz R, Fought A, Ivancic D, Shappell C, Allu S, et al.
Horm Cancer
. 2016 Feb;
7(2):127-36.
PMID: 26902826
Prior reports identify higher serum concentrations of estrogens and androgens as risk factors for breast cancer, but steroids in nipple aspirate fluid (NAF) may be more related to risk. Incident...
10.
Monahan D, Wang J, Lee O, Revesz E, Taft N, Ivancic D, et al.
Surg Oncol
. 2016 Feb;
25(4):449-456.
PMID: 26856771
Purpose: The contralateral unaffected breast (CUB) of women with unilateral breast cancer provides a model for the study of breast tissue-based risk factors. Using random fine needle aspiration (rFNA), we...